PRELIMINARY PROGRAM - May be subject to change.

Working titles shown.  Final titles will be announced.

Educational Sessions

     NEW this year!  Designed to provide opportunities for clinicians and investigators who may be lacking

     access to these important aspects of breast cancer treatment and research.

     Emerging Targets

     José Baselga, MD, Vall d'Hebron University Hospital

     Douglas Yee, MD, University of Minnesota

     Signal Transduction Pathways Controlling Proliferation and Death in Breast Cancer

     Carlos Arteaga, MD, Vanderbilt-Ingram Cancer Center

     Anthony Letai, MD, PhD, Dana-Farber Cancer Institute

     Clinical Trials 101

     Susan Hilsenbeck, PhD, Baylor College of Medicine

     Martine Piccart, MD, PhD, Jules Bordet Institute

     Pathobiology

     Andrea Richardson, MD, PhD, Dana-Farber Cancer Insitute

     TBA

Basic Science Panel Discussions

     Do Breast Cancer Stem Cells Exist?

Moderator:  Jeffrey Rosen, MD, PhD, Baylor College of Medicine

Max Wicha, MD, University of Michigan

Kornelia Polyak, MD, PhD, Dana-Farber Cancer Institute

     Genetic changes in the stroma – yes or no?

Moderator: Charlotte Kuperwasser, PhD, Tufts University

Charis Eng, MD, PhD, Case Western Reserve University School of Medicine

Kornelia Polyak, MD, PhD, Dana-Farber Cancer Institute

Case Discussions

The William L. McGuire Memorial Lectureship

    Larry Norton, MD, Memorial Sloan-Kettering Cancer Center

AACR Senior Investigator Award

     Micro RNA and Metastases

     Joan Massague, PhD, Memorial Sloan-Kettering Cancer Center

Susan G. Komen for the Cure Young Investigator Award

     TBA

Susan G. Komen for the Cure Brinker Awards for Scientific Distinction

     TBA

Plenary Lectures

     Circulating Tumor Cells

     Klaus Pantel, MD, University Medical Center Hamburg-Eppendorf Institute of Tumor Biology

     Signal Transduction and Endocrine Therapy Combination

     Stephen Johnston, MD, PhD, FRCP, Royal Marsden NHS Foundation Trust and Institute of Cancer

     Research

Mini-Symposia

     Risk Assesment and Risk Reduction Strategies

Moderators:

J. Dirk Iglehart, MD, Dana-Farber Cancer Institute

Lynn C. Hartmann, MD, Mayo Clinic

Risk and risk reduction

Lynn C. Hartmann, MD, Mayo Clinic

Trends in the use of prophylactic surgery

Todd M. Tuttle, MD, MPH, University of Minnesota

Use of prophylactic surgery

William C. Wood, MD, Emory University School of Medicine

Deployment of risk assessment tools

Joann G. Elmore, MD, MPH, University of Washington

     Molecular Profiling for Guiding Therapeutic Decisions

Moderators:

Suzanne A.W. Fuqua, PhD, Baylor College of Medicine

Laura van't Veer, PhD, Netherlands Cancer Institute

RNA

Laura van't Veer, PhD, Netherlands Cancer Institute

Systems approach to personalized molecular medicine

Gordon B. Mills, MD, PhD, UT, M.D. Anderson Cancer Center

Susceptibility & clinical outcome

Professor Doug Easton, PhD, FMedSci, University of Cambridge

     New Data on Imaging

Moderators:

Judy Garber, MD, Dana-Farber Cancer Institute

David Mankoff, MD, PhD, University of Washington

Overview of modalities and PET imaging

David Mankoff, MD, PhD, University of Washington

Breast ultrasound

Wendi A. Berg, MD, Johns Hopkins Breast Center

Breast MRI

Mitchell D. Schnall, MD, PhD, University of Pennsylvania

Molecular imaging

David R. Piwnica-Worms, MD, PhD, Washington University